Sale Date Ended
“A critical guide for successfully conducting clinical trials”
Arun Bhatt, President, Clininvent Research
Girish S. Gudi, Vice President, Drug Metabolism and Pharmacokinetics, Glenmark Pharmaceuticals
Zinobia Madan, Founder & Managing Director, ClinOma Healthcare
Mandeep S. Oberoi, President & CEO, Clintrials Research (USA)
Ammar Raza, Associate Director- Medical Affairs, AstraZeneca
Viraj Rajadhyaksha, Associate Director - Medical Liaison, Sanofi-Aventis
Arani Chatterjee, Vice President, Clinical Research, Panacea Biotec
Rohit Arora, Deputy Director, Sanofi Pasteur
Parminder Kaur, Managing Director, RegPak BioPharma Consulting (Netherlands)
Chirag Trivedi, Head - Medical Affaris Clinical Operations, Sanofi-Aventis
Kiran Marthak, Director, Veeda Clinical Research
Milind Antani, Head-Pharma LifeSciences group, Nishith Desai Associates
Shubhangi Desai, Associate Director, SIRO Clinpharm
S. K. Gupta, Director General & Dean, ICRI (Institute of Clinical Research India)
Rajesh Jain, General Manager & Head of Operations, ECCRO India Services
Murtuza S. Bughediwala, General Manager, Clinical Operations & Business Development, Clininvent Research
Poonam Sule, Senior Manager - Clinical Research (International), Wockhardt
Jeroze Dalal, General Manager Clinical Operations, GlaxoSmithKline
India has billion plus population and a home for various life threatening diseases. However, these disadvantages provide an opportunity for global medical practitioners and healthcare providers to look India as an effective destination for research and clinical studies. India has registered fast growth in the number of clinical trials over the past few years, reflecting that the country has become one of the most attractive destinations for medical research. India represents a fast growing market for clinical research and studies. The country has managed to position itself as one of the leading destinations for clinical trials over the past few years. The number of clinical trials has increased, which has provided a boost to the country’s reputation as a leading destination for these types of studies. The availability of world-class healthcare infrastructure, skilled medical professionals, and low cost for patients and volunteers are some of the main factors driving growth in this industry. The market is expected to perform well in future also and will reach US$ 768 Million by 2013, registering a CAGR of 29% since 2009.
2nd Annual Clinical Trials Asia Summit 2011 will examine the current issues faced in clinical trials operations, addressing the risks, timeline and budget stipulations, while effectively tackling key challenges in overcoming trials agreement and site contract arbitration problems. This summit will discuss the operational element of trial site management, strategic partnership with CROs and SMOs, patient, talent & investigators management in order to improve & optimise the overall drug development effectiveness and ROI. Discover on how to implement and benefit from electronic data management & monitoring cost effectively. This conference will be shared by leading industrial practitioners across the region to promote practical discussions; especially on the know-how to manage needs, variability of different countries and institutions to enhance clinical operational excellence and vigilance.
Attendees will have the chance to learn, network and benchmark against the global top pharmas and local industry leaders on the best practices in talent, site, budget and performance management in clinical trials. The conference aims to provide a detailed analysis of what it takes to conduct clinical trials from a biopharmaceuticals and vaccines perspective in India and China and also addressing risk/benefit balance, anecdotal experiences of the multinational pharmaceutical industry in India and China, selection and role of CROs, logistics of operations, clinical trials management, government policies and pharmacovigilance.
2nd Annual Clinical Trials Asia Summit 2011 will provide you with the data that you need to recognize this complex and rapidly-expanding sector. Knowing the future market, and what impact will that have on future business opportunities? This is your opportunity to stay ahead by learning the latest trends and networking with the trend setters.
It gives us immense pleasure in welcoming you to the Clinical Trials Asia Summit '2011
Key themes discussed at this summit
Why should you attend
2nd Annual Clinical Trials Asia Summit 2011 - “A critical guide for successfully conducting clinical trials”
Get more from the event, with a broader scope bringing the whole communications value chain together. Enjoy and make the best out of our dedicated networking drinks time, meet the leading international vendors showcasing the products of tomorrow in the co-located exhibition. Expand your knowledge of the latest business models and strategies in the high-level conference.